JAK2 and cancer: Hsp90 is often overexpressed and associated with poor prognosis in a variety of tumors because it promotes the activation of oncogenic protein kinases, e.g., JAK2/STAT3, PI3K/AKT, and MAPK, facilitating cancer progression [7,21,32,33].